Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04143230
What this trial is testing

Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool

Who this might be right for
Locally Advanced CancerMetastatic CancerChronic Respiratory Failure+3 more
A.O.U. Città della Salute e della Scienza 660
Not applicableUnknownNCT06342323
What this trial is testing

The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

Who this might be right for
Lung CancerLiver CancerPancreatic Cancer+1 more
Peking University Third Hospital 57
Testing effectiveness (Phase 2)Study completedNCT02127710
What this trial is testing

A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

Who this might be right for
Papillary Renal Cell Cancer
AstraZeneca 111
Large-scale testing (Phase 3)Study completedNCT01265810
What this trial is testing

Caphosol in Oral Mucositis Due to Targeted Therapy

Who this might be right for
Oral ComplaintsRenal Cell CarcinomaHepatocellular Carcinoma+1 more
Impaqtt Foundation 64
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Testing effectiveness (Phase 2)Ended earlyNCT02853162
What this trial is testing

Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)

Who this might be right for
Renal Cell Carcinoma
UMC Utrecht 30
Early research (Phase 1)Study completedNCT04846920
What this trial is testing

Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 29
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Not applicableActive Not RecruitingNCT04258813
What this trial is testing

Onco-primary Care Networking to Support TEAM-based Care

Who this might be right for
Blood PressureHypertensionCancer+15 more
Duke University 313
Testing effectiveness (Phase 2)Active Not RecruitingNCT06584435
What this trial is testing

Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer

Who this might be right for
High-risk Renal Cell Carcinoma
Tianjin Medical University Second Hospital 100
Not applicableUnknownNCT04392076
What this trial is testing

Image Guided RFA/MWA/CRYO of RCC Biomarker Profile Study

Who this might be right for
Renal Cancer
University of Leeds 43
Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00934440
What this trial is testing

Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas Medical Center 11
Post-approval studies (Phase 4)Study completedNCT00666978
What this trial is testing

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Lisa Sanderson Cox, PhD 540
Not applicableStudy completedNCT03064308
What this trial is testing

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery

Who this might be right for
Impaired CognitionQuality of LifeSurgery+7 more
University of Nottingham 11
Not applicableStudy completedNCT02329808
What this trial is testing

Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics

Who this might be right for
Hematologic DiseasesOncology ProblemKidney Diseases+1 more
Radboud University Medical Center 93
Not applicableStudy completedNCT07004426
What this trial is testing

Symptomatic and Incidental RCC Detection

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Benign Renal NeoplasmRenal Carcinoma
Charles University, Czech Republic 1,000
Not applicableEnded earlyNCT02131376
What this trial is testing

Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy

Who this might be right for
Renal Cell Carcinoma
Indiana University 26
Testing effectiveness (Phase 2)Study completedNCT00057889
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Institutes of Health Clinical Center (CC)
Next Page